Kairos Pharma, Ltd. (KAPA)

AMEX·Healthcare·Biotechnology

$0.45

-2.14%

Mkt Cap $12.83M

No analyst coverage available

We don't have analyst ratings or price target data for Kairos Pharma, Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.